Scientists Discover New Method for Cancer Drug Creation
Researchers from the University of Warwick and Monash University have identified how bacterial enzymes cooperate to create diverse anti-cancer drug variants. This discovery of 'docking domains' allows scientists to potentially engineer new, more effective cancer therapies.
Why it matters
Understanding this biological mechanism could revolutionize drug development, making it easier to create targeted treatments for complex cancers.
A team of researchers at the University of Warwick and Monash University has solved a puzzle that's stumped drug developers for decades: how bacteria naturally create multiple versions of powerful cancer therapies. The breakthrough could accelerate development of new treatments for hard-to-treat cancers.
The report is a straightforward summary of scientific findings published in a peer-reviewed journal.
Get smarter about the news
Sign up free for a feed built around what you actually care about, Dive Deeper research on any story, and the full text of every article.
Create free accountAlready have an account? Sign in